Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort
{{output}}
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a cardiovascular risk-enhancing condition. Its prognostic significance following PCI in non-diabetic adults, and the temporal distribution of that ri... ...
